ArticlePloS one2020

Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials.

Xiaoyin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.